Literature DB >> 27546617

Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention.

F Wendler1, R Favicchio2, T Simon1, C Alifrangis3, J Stebbing2, G Giamas1.   

Abstract

Intercellular communication sets the pace for transformed cells to survive and to thrive. Extracellular vesicles (EVs), such as exosomes, microvesicles and large oncosomes, are involved in this process shuttling reciprocal signals and other molecules between transformed and stromal cells, including fibroblasts, endothelial and immune cells. As a result, these cells are adapted or recruited to a constantly evolving cancer microenvironment. Moreover, EVs take part in the response to anticancer therapeutics not least by promoting drug resistance throughout the targeted tumor. Finally, circulating EVs can also transport important molecules to remote destinations in order to prime metastatic niches in an otherwise healthy tissue. Although the understanding of EV biology remains a major challenge in the field, their characteristics create new opportunities for advances in cancer diagnostics and therapeutics.

Entities:  

Mesh:

Year:  2016        PMID: 27546617     DOI: 10.1038/onc.2016.253

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  86 in total

1.  Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro.

Authors:  Li-Hong Lv; Yun-Le Wan; Yan Lin; Wei Zhang; Mei Yang; Guo-Lin Li; Hao-Ming Lin; Chang-Zhen Shang; Ya-Jin Chen; Jun Min
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

2.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.

Authors:  L Zitvogel; A Regnault; A Lozier; J Wolfers; C Flament; D Tenza; P Ricciardi-Castagnoli; G Raposo; S Amigorena
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

3.  Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells.

Authors:  Bas W M van Balkom; Olivier G de Jong; Michiel Smits; Jolanda Brummelman; Krista den Ouden; Petra M de Bree; Monique A J van Eijndhoven; D Michiel Pegtel; Willem Stoorvogel; Thomas Würdinger; Marianne C Verhaar
Journal:  Blood       Date:  2013-03-26       Impact factor: 22.113

4.  Secreted monocytic miR-150 enhances targeted endothelial cell migration.

Authors:  Yujing Zhang; Danqing Liu; Xi Chen; Jing Li; Limin Li; Zhen Bian; Fei Sun; Jiuwei Lu; Yuan Yin; Xing Cai; Qi Sun; Kehui Wang; Yi Ba; Qiang Wang; Dongjin Wang; Junwei Yang; Pingsheng Liu; Tao Xu; Qiao Yan; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

5.  Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes.

Authors:  Jung Eun Park; Hon Sen Tan; Arnab Datta; Ruenn Chai Lai; Huoming Zhang; Wei Meng; Sai Kiang Lim; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2010-02-01       Impact factor: 5.911

6.  Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.

Authors:  Valbona Luga; Liang Zhang; Alicia M Viloria-Petit; Abiodun A Ogunjimi; Mohammad R Inanlou; Elaine Chiu; Marguerite Buchanan; Abdel Nasser Hosein; Mark Basik; Jeffrey L Wrana
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

7.  Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications.

Authors:  Marco Ragusa; Luisa Statello; Marco Maugeri; Cristina Barbagallo; Roberta Passanisi; Mohamed S Alhamdani; Giovanni Li Destri; Alessandro Cappellani; Davide Barbagallo; Marina Scalia; Hadi Valadi; Jörg D Hoheisel; Cinzia Di Pietro; Michele Purrello
Journal:  Oncoscience       Date:  2014-03-16

Review 8.  Extracellular vesicles: emerging targets for cancer therapy.

Authors:  Pieter Vader; Xandra O Breakefield; Matthew J A Wood
Journal:  Trends Mol Med       Date:  2014-04-03       Impact factor: 11.951

9.  Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes.

Authors:  M Aga; G L Bentz; S Raffa; M R Torrisi; S Kondo; N Wakisaka; T Yoshizaki; J S Pagano; J Shackelford
Journal:  Oncogene       Date:  2014-03-24       Impact factor: 9.867

10.  Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities.

Authors:  Emma M Kerr; Edoardo Gaude; Frances K Turrell; Christian Frezza; Carla P Martins
Journal:  Nature       Date:  2016-02-24       Impact factor: 49.962

View more
  59 in total

1.  MiRNA extraction from cell-free biofluid using protein corona formed around carboxyl magnetic nanoparticles.

Authors:  Shengqiang Xu; Seyedmehdi Hossaini Nasr; Daoyang Chen; Xiaoxian Zhang; Liangliang Sun; Xuefei Huang; Chunqi Qian
Journal:  ACS Biomater Sci Eng       Date:  2017-12-18

2.  A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells.

Authors:  Sukhbir Kaur; Abdel G Elkahloun; Satya P Singh; Anush Arakelyan; David D Roberts
Journal:  J Cell Commun Signal       Date:  2017-11-29       Impact factor: 5.782

Review 3.  Extracellular Vesicles: How the External and Internal Environment Can Shape Cell-To-Cell Communication.

Authors:  Kristof Y Neven; Tim S Nawrot; Valentina Bollati
Journal:  Curr Environ Health Rep       Date:  2017-03

4.  Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapies.

Authors:  Zhen Lu; Angelica Ortiz; Ioannis I Verginadis; Amy R Peck; Farima Zahedi; Christina Cho; Pengfei Yu; Rachel M DeRita; Hongru Zhang; Ryan Kubanoff; Yunguang Sun; Andrew T Yaspan; Elise Krespan; Daniel P Beiting; Enrico Radaelli; Sandra W Ryeom; J Alan Diehl; Hallgeir Rui; Constantinos Koumenis; Serge Y Fuchs
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

5.  Role of Asparagine Endopeptidase in Mediating Wild-Type p53 Inactivation of Glioblastoma.

Authors:  Yingying Lin; Keman Liao; Yifeng Miao; Zhongrun Qian; Zhaoyuan Fang; Xi Yang; Quanmin Nie; Gan Jiang; Jianhua Liu; Yiyi Yu; Jieqing Wan; Xiaohua Zhang; Yaomin Hu; Jiyao Jiang; Yongming Qiu
Journal:  J Natl Cancer Inst       Date:  2020-04-01       Impact factor: 13.506

6.  Adipose-derived exosomes deliver miR-23a/b to regulate tumor growth in hepatocellular cancer by targeting the VHL/HIF axis.

Authors:  Yang Liu; Juan Tan; Shuangyan Ou; Jun Chen; Limin Chen
Journal:  J Physiol Biochem       Date:  2019-07-18       Impact factor: 4.158

Review 7.  A new role for extracellular vesicles: how small vesicles can feed tumors' big appetite.

Authors:  Ikrame Lazar; Emily Clement; Camille Attane; Catherine Muller; Laurence Nieto
Journal:  J Lipid Res       Date:  2018-04-20       Impact factor: 5.922

Review 8.  Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.

Authors:  Sachin Kumar Deshmukh; Sanjeev K Srivastava; Nikhil Tyagi; Aamir Ahmad; Ajay P Singh; Ahmed A L Ghadhban; Donna L Dyess; James E Carter; Kari Dugger; Seema Singh
Journal:  Carcinogenesis       Date:  2017-08-01       Impact factor: 4.944

9.  Mastocytosis-derived extracellular vesicles exhibit a mast cell signature, transfer KIT to stellate cells, and promote their activation.

Authors:  Do-Kyun Kim; Young-Eun Cho; Hirsh D Komarow; Geethani Bandara; Byoung-Joon Song; Ana Olivera; Dean D Metcalfe
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-23       Impact factor: 11.205

10.  The effect of storage temperature on the biological activity of extracellular vesicles for the complement system.

Authors:  Sang June Park; Hyungtaek Jeon; Seung-Min Yoo; Myung-Shin Lee
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-05-10       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.